Skip to content

Clinical trials

Phase 2 Parkinson Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Country / region: United States Clear all

223 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20026
20039
20048
20057
20069
20076
20086
20096
20108
20117
20127
20136
20145
20155
201613
201714
201813
20198
202011
202112
202210
20238
20246
20258
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed147
Terminated25
Recruiting20
Active, not recruiting12
Unknown status10
Withdrawn7
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)17
Institute for Neurodegenerative Disorders7
Novartis Pharmaceuticals5
Oregon Health and Science University5
Eisai Inc.4
Impax Laboratories, LLC4
Northwestern University4
Pfizer4
University of Rochester4
Biogen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease223
Dyskinesias30
Movement Disorders21
Neurodegenerative Diseases10
Parkinsonian Disorders10
Central Nervous System Diseases7
Cognitive Dysfunction6
Anxiety Disorders5
Psychotic Disorders5
Tremor5

Trials

Showing 1 to 25 of 223. Each trial links to its page on Pharma Observatory.

123 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.